TY - JOUR
T1 - Selective coupling of α2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells
AU - Pepperl, D. J.
AU - Regan, J. W.
PY - 1993/10
Y1 - 1993/10
N2 - A cAMP-dependent reporter gene has been used in transiently transfected human choriocarcinoma (JEG-3) cells to examine the second messenger coupling of the human α2-adrenergic receptor subtypes. The reporter gene consists of a cAMP response element linked to the gene for chloramphenicol acetyltransferase (CAT). Plasmids encoding the α2-C10 (α2A), α2-C2 (α2B), or α2-C4 (α2C) receptor subtypes were co-transfected with a plasmid containing the reporter gene, and the ability of α2 receptor agonists to influence forskolin-stimulated CAT expression was examined. For α2-C10, agonists had a biphasic effect on forskolin-stimulated CAT expression. Thus, low (nanomolar) concentrations of agonist inhibited CAT expression by ∼60%, whereas high (micromolar) concentrations reversed this inhibition and could even potentiate CAT expression by as much as 140%. A significantly different pattern of coupling was observed for the other α2 receptor subtypes. For α2-C4, agonists only inhibited forskolin-stimulated CAT expression, whereas for α2-C2 only potentiation of expression was seen. Each of these responses was specifically blocked by α2- but not α1- or β-adrenergic receptor antagonists. For α2-C4, the inhibition of forskolin-stimulated CAT expression was prevented by pretreatment of the cells with pertussis toxin. This was also true for the inhibition obtained with α2-C10. The potentiation of CAT expression, however, was not prevented by pertussis toxin pretreatment in cells transfected with either α2-C2 or α2-C10. In this transient expression system, each α2-adrenergic receptor subtype had access to the same complement of G proteins, adenylyl cyclase, and other second messengers. It would appear, therefore, that the potential for the activation of unique intracellular responses exists even among closely related receptor subtypes.
AB - A cAMP-dependent reporter gene has been used in transiently transfected human choriocarcinoma (JEG-3) cells to examine the second messenger coupling of the human α2-adrenergic receptor subtypes. The reporter gene consists of a cAMP response element linked to the gene for chloramphenicol acetyltransferase (CAT). Plasmids encoding the α2-C10 (α2A), α2-C2 (α2B), or α2-C4 (α2C) receptor subtypes were co-transfected with a plasmid containing the reporter gene, and the ability of α2 receptor agonists to influence forskolin-stimulated CAT expression was examined. For α2-C10, agonists had a biphasic effect on forskolin-stimulated CAT expression. Thus, low (nanomolar) concentrations of agonist inhibited CAT expression by ∼60%, whereas high (micromolar) concentrations reversed this inhibition and could even potentiate CAT expression by as much as 140%. A significantly different pattern of coupling was observed for the other α2 receptor subtypes. For α2-C4, agonists only inhibited forskolin-stimulated CAT expression, whereas for α2-C2 only potentiation of expression was seen. Each of these responses was specifically blocked by α2- but not α1- or β-adrenergic receptor antagonists. For α2-C4, the inhibition of forskolin-stimulated CAT expression was prevented by pretreatment of the cells with pertussis toxin. This was also true for the inhibition obtained with α2-C10. The potentiation of CAT expression, however, was not prevented by pertussis toxin pretreatment in cells transfected with either α2-C2 or α2-C10. In this transient expression system, each α2-adrenergic receptor subtype had access to the same complement of G proteins, adenylyl cyclase, and other second messengers. It would appear, therefore, that the potential for the activation of unique intracellular responses exists even among closely related receptor subtypes.
UR - http://www.scopus.com/inward/record.url?scp=0027332135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027332135&partnerID=8YFLogxK
M3 - Article
C2 - 8232231
AN - SCOPUS:0027332135
SN - 0026-895X
VL - 44
SP - 802
EP - 809
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 4
ER -